[
    {
        "speaker": "Tom Mansell",
        "timestamp": "00:00-00:13",
        "transcript": "Sensing and regulation is a big part of the plan here. But for now, we're in the very preliminary stages of that.",
        "speaking_duration": 13,
        "nods_others": 2,
        "smile_self": 0,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document is shared on the screen. The document appears to be a research plan or proposal. No changes are made to the document during this segment.",
        "start_time": "00:00",
        "end_time": "00:13",
        "annotations": {
            "codes": [
                {
                    "code_name": "Highlights significant undeveloped areas",
                    "definition": "The speaker identifies a critical component of a potential plan or idea but explicitly states that it is currently in its very early, undeveloped stages. This can signal a lack of immediate readiness for collaborative work or grant submission, potentially deterring partners.",
                    "justification": "The speaker explicitly states, \"Sensing and regulation is a big part of the plan here. But for now, we're in the very preliminary stages of that,\" indicating that a crucial aspect of their plan is currently undeveloped, which might discourage immediate collaborative engagement or raise concerns about project readiness for funding."
                }
            ]
        }
    },
    {
        "speaker": "Tanya Nguyen",
        "timestamp": "00:13-01:02",
        "transcript": "To follow up on what you're saying and also what Jay had mentioned earlier, and I have no idea how to do this, but it would be so cool to develop a way to kind of individually determine what someone's microbiome is at homeostasis, their ideal kind of microbiome environment, whether that be composition, metabolites, chemicals, and then use that as a baseline, and then being able to develop, you know, these different chemically engineered bacteria then produce specific metabolites to keep that person at that specific ideal level or attain an ideal level for them to then minimize their clinical symptoms or functioning. I think that would be a really cool idea, no idea how to get there, but happy to talk about it further and develop that.",
        "speaking_duration": 49,
        "nods_others": 3,
        "smile_self": 20,
        "smile_other": 10,
        "distracted_others": 0,
        "hand_gesture": "Open Palms",
        "interuption": "Yes",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "00:13",
        "end_time": "01:02",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of concrete plan",
                    "definition": "The speaker proposes a complex or ambitious idea but explicitly states an inability to outline specific steps or a clear methodology for its execution.",
                    "justification": "The speaker introduces a broad research concept but immediately admits, \"I have no idea how to do this\" and later reiterates, \"no idea how to get there,\" indicating a lack of a practical plan for the proposed idea."
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:02-01:13",
        "transcript": "I think you could do it with one molecule. I don't know about all of those. But you know, if it's short chain fatty acids, I think that that's a great idea.",
        "speaking_duration": 11,
        "nods_others": 0,
        "smile_self": 30,
        "smile_other": 60,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:02",
        "end_time": "01:13",
        "annotations": {
            "codes": [
                {
                    "code_name": "Narrows scope of idea",
                    "definition": "The speaker immediately reduces the complexity or breadth of a previously proposed idea, suggesting a simpler or more limited approach.",
                    "justification": "The speaker dismisses the multi-faceted nature of the previous idea by stating, \"I don't know about all of those,\" and then suggests a significantly simpler approach: \"I think you could do it with one molecule.\""
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:13-01:26",
        "transcript": "Right now, I think, in general, the approaches, well, let's just make more, make more given prebiotics, given probiotics that we think are going to make butyrate. But you know, there might, there's probably a level that's too high, right?",
        "speaking_duration": 13,
        "nods_others": 1,
        "smile_self": 0,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:13",
        "end_time": "01:26",
        "annotations": {
            "codes": [
                {
                    "code_name": "Identifies problem without solution",
                    "definition": "The speaker points out a significant limitation or problem with an existing approach or idea without offering a potential solution or a path forward.",
                    "justification": "The speaker highlights a potential issue with current methods, stating, 'But you know, there might, there's probably a level that's too high, right?', without immediately proposing how to address this limitation."
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:26-01:38",
        "transcript": "Do they take 12 different probiotic supplements every day to maintain that? You know, that's kind of the, yeah, so.",
        "speaking_duration": 12,
        "nods_others": 0,
        "smile_self": 40,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:26",
        "end_time": "01:38",
        "annotations": {
            "codes": [
                {
                    "code_name": "Raising impracticality",
                    "definition": "The speaker highlights significant practical difficulties or extreme scenarios associated with an idea or approach, without offering constructive solutions or ways to mitigate these issues.",
                    "justification": "The speaker uses a rhetorical question to emphasize the logistical challenge of maintaining an ideal state, stating, 'Do they take 12 different probiotic supplements every day to maintain that?' This focuses on an extreme impracticality without offering a solution."
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:40-01:56",
        "transcript": "Yeah, no, that's a good idea. I mean, there is this whole, you know, what's a healthy microbiome, what's a healthy metabolome. That's, I think, going to vary by the host, and these host factors really influence these things, right? So, in addition to diet, of course, right?",
        "speaking_duration": 18,
        "nods_others": 1,
        "smile_self": 0,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:40",
        "end_time": "01:56",
        "annotations": {
            "codes": [
                {
                    "code_name": "Raising obstacles without proposing solutions",
                    "definition": "The speaker identifies complexities, challenges, or limitations related to a proposed idea or problem without offering potential solutions, strategies, or constructive ways to overcome them. This can stifle innovation and collaboration by focusing solely on difficulties.",
                    "justification": "While acknowledging the previous idea as 'good,' the speaker immediately pivots to general scientific complexities and variability, stating, 'what's a healthy microbiome, what's a healthy metabolome. That's, I think, going to vary by the host, and these host factors really influence these things, right? So, in addition to diet, of course, right?' without suggesting how to address these challenges within the context of the proposed idea."
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:56-02:07",
        "transcript": "You can blame it on behavior a little bit, but also there's probably genetic factors too, right, that influence your microbiome. I'm just gabbling, yeah.",
        "speaking_duration": 11,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:56",
        "end_time": "02:07",
        "annotations": {
            "codes": [
                {
                    "code_name": "Self-deprecation",
                    "definition": "The speaker explicitly devalues or dismisses their own contribution, often using phrases that suggest their input is trivial or rambling.",
                    "justification": "The speaker explicitly undermines their own contribution by stating, \"I'm just gabbling,\" which can signal a lack of confidence or seriousness in their ideas."
                }
            ]
        }
    },
    {
        "speaker": "Jae Sung",
        "timestamp": "02:15-02:23",
        "transcript": "I guess we have many more questions than answers. That's because that's how science works. Very interesting.",
        "speaking_duration": 8,
        "nods_others": 0,
        "smile_self": 80,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "02:15",
        "end_time": "02:23",
        "annotations": {
            "codes": [
                {
                    "code_name": "Generalizing/Abstracting",
                    "definition": "The speaker shifts the discussion to a high-level, abstract, or philosophical point, avoiding engagement with specific details or proposed solutions, which can hinder progress on concrete ideas.",
                    "justification": "Jae Sung responds to a detailed discussion by making a broad, philosophical statement about the nature of science ('I guess we have many more questions than answers. That's because that's how science works.') rather than engaging with the specific technical points previously discussed, followed by a generic 'Very interesting.'"
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "02:27-02:46",
        "transcript": "I just have to say, as a chemical engineer, the thing that I have gotten most out of this discussion is this motility concept, right? And so we talked, you know, Emily framed the discussion as, this is a bioreactor, right? This is, we have a whole core curriculum on this on reactor design.",
        "speaking_duration": 19,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "02:27",
        "end_time": "02:46",
        "annotations": {
            "codes": [
                {
                    "code_name": "Disciplinary Dominance",
                    "definition": "The speaker explicitly asserts their disciplinary identity and frames the discussion or a concept primarily through the lens of their own field, potentially limiting the scope or devaluing other perspectives.",
                    "justification": "The speaker explicitly states their professional identity and immediately connects the discussion to a core concept within their field, emphasizing its established nature: 'I just have to say, as a chemical engineer, the thing that I have gotten most out of this discussion is this motility concept... we have a whole core curriculum on this on reactor design.' This framing can inadvertently narrow the problem scope to fit one discipline's framework, potentially hindering interdisciplinary collaboration."
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "02:46-03:17",
        "transcript": "A key parameter of reactor design is residence time, which is the flow rate divided by the volume, right? So, that motility, being the flow rate, is going to influence the conversion or whatever fermentation products come out of your reactor, right? And so, I love this idea of influencing motility as a way to manipulate the microbiome, and in doing so, manipulate the metabolome.",
        "speaking_duration": 31,
        "nods_others": 1,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "02:46",
        "end_time": "03:17",
        "annotations": {
            "codes": [
                {
                    "code_name": "Didactic/Lecturing Tone",
                    "definition": "The speaker adopts an instructional or explanatory tone, presenting information as if teaching or informing others, which may discourage reciprocal contribution.",
                    "justification": "The speaker explains a technical concept and its application in a manner that sounds like an explanation rather than an open-ended discussion point: 'A key parameter of reactor design is residence time, which is the flow rate divided by the volume, right? So, that motility, being the flow rate, is going to influence the conversion or whatever fermentation products come out of your reactor, right?'"
                },
                {
                    "code_name": "Disciplinary Siloing",
                    "definition": "The speaker frames the discussion predominantly through the lens of their specific discipline, potentially limiting the integration of diverse perspectives.",
                    "justification": "The speaker explicitly introduces and frames the discussion using concepts from their specific field of expertise, stating: 'A key parameter of reactor design is residence time, which is the flow rate divided by the volume, right?'"
                }
            ]
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "03:18-03:22",
        "transcript": "It's circular, and then it affects motility again.",
        "speaking_duration": 4,
        "nods_others": 0,
        "smile_self": 60,
        "smile_other": 20,
        "distracted_others": 0,
        "hand_gesture": "Pointing",
        "interuption": "Yes",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:18",
        "end_time": "03:22",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "03:22-03:23",
        "transcript": "Right.",
        "speaking_duration": 1,
        "nods_others": 0,
        "smile_self": 0,
        "smile_other": 80,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:22",
        "end_time": "03:23",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "03:23-03:41",
        "transcript": "Yes, of course. And you know, like many processes, it probably is a small disruption that becomes non-linear, and then, you know, that's when you end up in a disease state. I don't know, I'm not that kind of doctor, but",
        "speaking_duration": 18,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:23",
        "end_time": "03:41",
        "annotations": {
            "codes": [
                {
                    "code_name": "Hedging",
                    "definition": "The speaker qualifies a statement with cautious or evasive language, potentially reducing its impact or their perceived commitment to the idea.",
                    "justification": "The speaker hedges their speculative statement about disease states by explicitly stating, \"I don't know, I'm not that kind of doctor, but\", which may diminish the perceived confidence or authority behind their contribution."
                }
            ]
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "03:41-03:46",
        "transcript": "So, Faranak, I think we should talk about your ENS essay a little more.",
        "speaking_duration": 5,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 60,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:41",
        "end_time": "03:46",
        "annotations": {
            "codes": [
                {
                    "code_name": "Directing Conversation",
                    "definition": "The speaker explicitly attempts to steer the discussion towards a specific topic or individual's work, which can limit the organic flow of ideas or broader participation.",
                    "justification": "The speaker explicitly suggests a specific topic for the group to discuss, stating, \"I think we should talk about your ENS essay a little more.\""
                }
            ]
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "03:46-04:15",
        "transcript": "Absolutely. Yeah, I'd love to. So we have actually done a lot of high throughput assays just looking at, you know, a library of neuroactive compounds. So these are around maybe 500 or 600 just small molecules that affect different neurotransmitter receptors. And turns out a lot of neurons in the GI tract respond to a variety of different neurotransmitter agonists and antagonists. And many of them could be influenced by microbial products.",
        "speaking_duration": 29,
        "nods_others": 2,
        "smile_self": 40,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:46",
        "end_time": "04:15",
        "annotations": {
            "codes": [
                {
                    "code_name": "Overly technical detail",
                    "definition": "Providing a level of technical specificity that might be more appropriate for a deeper dive or a specialized audience, potentially overwhelming or disengaging some participants in an initial broad discussion.",
                    "justification": "The speaker immediately delves into highly specific technical details, such as the exact number of compounds ('500 or 600') and the precise types of molecules ('neurotransmitter agonists and antagonists'), which, while informative, might be too granular for an initial exploratory meeting focused on identifying broad collaborative opportunities. For example: 'So these are around maybe 500 or 600 just small molecules that affect different neurotransmitter receptors. And turns out a lot of neurons in the GI tract respond to a variety of different neurotransmitter agonists and antagonists.'"
                }
            ]
        }
    },
    {
        "speaker": "Emily Balskus",
        "timestamp": "00:03-00:26",
        "transcript": "Okay, so we we probably have five minutes or so left, maybe um uh yeah, so thinking about and it looks like Jay Jay might have stepped away from his computer. Thinking about you sort of condensing and highlighting the key takeaways, um yeah, maybe Sarah.",
        "speaking duration": 23,
        "nods_others": 1,
        "smile_self": 65,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "Open Palms",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "10:03",
        "end_time": "10:26",
        "annotations": {
            "codes": [
                {
                    "code_name": "Publicly noting participant disengagement",
                    "definition": "The speaker explicitly observes and states that another participant appears disengaged or absent from the discussion.",
                    "justification": "The speaker notes, \"it looks like Jay Jay might have stepped away from his computer,\" publicly highlighting Jay Jay's potential disengagement or absence, which can create an awkward social dynamic."
                }
            ]
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "00:26-00:57",
        "transcript": "I guess for me the the main takeaways are we have um so the field has identified many interesting correlations between um certain fermentation products and neurological disorders. Um and so we know that those actually are relevant to actual clinical data and in my mouse models. And so we are expanding, we are hoping to expand our knowledge of what other products might be important in like overall neurological.",
        "speaking duration": 31,
        "nods_others": 0,
        "smile_self": 0,
        "smile_other": 100,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "10:26",
        "end_time": "10:57",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of conciseness",
                    "definition": "The speaker provides an overly detailed or lengthy explanation when a brief summary or direct answer is expected, potentially consuming valuable meeting time.",
                    "justification": "The speaker offers a detailed account of the field's findings and her own research, despite the facilitator's preceding request to 'condense and highlight the key takeaways' due to limited time. The utterance itself is quite long: 'I guess for me the the main takeaways are we have um so the field has identified many interesting correlations between um certain fermentation products and neurological disorders. Um and so we know that those actually are relevant to actual clinical data and in my mouse models. And so we are expanding, we are hoping to expand our knowledge of what other products might be important in like overall neurological. .'"
                },
                {
                    "code_name": "Individual focus",
                    "definition": "The speaker primarily highlights their own research, models, or future plans, rather than framing their contributions in a way that explicitly invites collaboration or identifies shared interests with other participants.",
                    "justification": "Faranak frames the 'main takeaways' from her perspective ('for me the the main takeaways') and then emphasizes her specific work and future directions: 'in my mouse models. And so we are expanding, we are hoping to expand our knowledge of what other products might be important in like overall neurological.' This focuses on her group's trajectory rather than potential joint ventures."
                }
            ]
        }
    },
    {
        "speaker": "Emily Balskus",
        "timestamp": "00:57-00:58",
        "transcript": "Oh we really don't have yeah.",
        "speaking duration": 1,
        "nods_others": 0,
        "smile_self": 100,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "Yes",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "10:57",
        "end_time": "10:58",
        "annotations": {
            "codes": [
                {
                    "code_name": "Interruption",
                    "definition": "The speaker breaks into another speaker's turn before they have finished, preventing them from completing their thought or statement.",
                    "justification": "Emily interjects with \"Oh we really don't have yeah. .\" while Faranak is in the middle of presenting her summary, cutting off her flow."
                }
            ]
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "01:00-01:44",
        "transcript": "And then we want to know if um we can build models to then get at the mechanistic steps where basically these um these products then you know, induce all these changes in the body that then translate into effects on the disease. Um I guess another important point was the medications and how they um get affected by the microbiome and then vice versa, how like management of these patients affects the motility and the composition of the microbes. So yeah, I guess Jay's back so.",
        "speaking duration": 44,
        "nods_others": 0,
        "smile_self": 10,
        "smile_other": 100,
        "distracted_others": 0,
        "hand_gesture": "Open Palms",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "11:00",
        "end_time": "11:44",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expansive elaboration despite time constraints",
                    "definition": "The speaker continues to introduce new ideas or elaborate on multiple points, expanding the scope of discussion, even when explicit or implicit cues indicate a need for conciseness or a summary due to limited time.",
                    "justification": "Faranak continues to introduce new research directions (\"And then we want to know if um we can build models to then get at the mechanistic steps...\", \"Um I guess another important point was the medications...\") immediately after Emily's utterance (\"Oh we really don't have yeah.\") signaled a lack of time, indicating a failure to condense or prioritize information."
                },
                {
                    "code_name": "Extended turn-taking",
                    "definition": "The speaker takes a significantly long turn, especially when time is limited or other participants are expected to contribute, potentially limiting opportunities for others to speak or for the discussion to progress efficiently.",
                    "justification": "Faranak's utterance is lengthy, continuing to elaborate on multiple research points (\"And then we want to know if um we can build models...\", \"Um I guess another important point was the medications...\") even after Emily's explicit cues about limited time, thereby extending her turn and potentially limiting others' contributions."
                }
            ]
        }
    },
    {
        "speaker": "Emily Balskus",
        "timestamp": "01:44-01:46",
        "transcript": "Thanks Jay.",
        "speaking duration": 2,
        "nods_others": 0,
        "smile_self": 100,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "11:44",
        "end_time": "11:46",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "speaker": "Jae Sung",
        "timestamp": "01:46-01:51",
        "transcript": "All right, I'm going to try to summarize all this to",
        "speaking duration": 5,
        "nods_others": 0,
        "smile_self": 100,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "11:46",
        "end_time": "11:51",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    }
]